🔎 Trials Near Me

Home › Migraine › Texas › Dallas

Migraine clinical trials in Dallas, TX

7 studies for Migraine are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Study of EVO756 in Adults With Migraine

RecruitingPhase 2
  • FutureSearch Trials of Dallas, Dallas
Ages 18 to 64 · All sexes · Updated Nov 13, 2026 · NCT07616128

A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

RecruitingPhase 3
  • Velocity Clinical Research, Dallas, Dallas
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT07816367

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

RecruitingPhase 3
  • FutureSearch Trials of Dallas, LP, Dallas
Ages 18 to 75 · All sexes · Updated Nov 2, 2026 · NCT07645924

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

RecruitingPhase 3
  • FutureSearch Trials of Dallas, LLC, Dallas
Ages 6 to 17 · All sexes · Updated Oct 27, 2026 · NCT04649242

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

RecruitingPhase 3
  • Alina Clinical Trials, LLC., Dallas
Ages 6 to 17 · All sexes · Updated Oct 14, 2026 · NCT05156398

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

RecruitingPhase 3
  • Relaro Medical Trials /ID# 239642, Dallas
  • Cedar Health Research /ID# 228003, Dallas
Ages 6 to 17 · All sexes · Updated Sep 14, 2026 · NCT05125302

About Migraine

Migraines are pulsing or throbbing headaches in one area of the head. Learn about other symptoms, what triggers migraines, and how to treat them.

More about Migraine on MedlinePlus

Migraine trials in other cities

Other studies in Dallas

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.